• ABOUT ELITE
    • Overview
    • Our Facility
    • Management & Key Employees
    • Our Board
    • Careers
  • PRODUCTS
  • PIPELINE
    • Generic
    • Branded
  • TECHNOLOGY
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • INVESTOR RELATIONS
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
logo image
HOME | CAREERS | CONTACT | NEWS |
Share
Skip to content
  • About Elite
    • Overview
    • Management & Key Employees
    • Our Board
    • Careers
  • Products
  • Pipeline
    • Generic
    • Branded
  • Technology
    • Technology Overview
    • How It Works
    • One Bead System
    • Two Bead System
  • Investor Relations
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Shareholder Meeting
    • Governance Documents
    • Investor Contacts
    • Email Alerts
    • Investor Relations
    • Press Releases
    • Events &
      Presentations
    • SEC Filings
    • Shareholder
      Meeting
    • Governance
      Documents
    • Investor Contacts
    • Email Alerts

Press Releases

 
Select:
May 25, 2006
Elite Pharmaceuticals Enters Second Pilot Phase I Trials Of Its Once-Daily Oxycodone Product

Mar 31, 2006
Elite Pharmaceuticals Reviews Key Highlights from Conference Call

Mar 23, 2006
ELITE PHARMACEUTICALS TO HOST CONFERENCE CALL TO REVIEW COMPANY DEVELOPMENTS

Mar 22, 2006
Elite Pharmaceutical's Continued Listing Plan Accepted by AMEX

Mar 16, 2006
ELITE ANNOUNCES CLOSING OF $10,000,000 PRIVATE PLACEMENT

Mar 13, 2006
ELITE TO PARTICIPATE IN FIRST ALBANY CAPITAL'S CHRONIC PAIN CONFERENCE DISCUSSING UNMET NEEDS IN OPIOID THERAPY

Jan 31, 2006
ELITE TO PARTICIPATE IN FIRST ALBANY CAPITAL'S CHRONIC PAIN CONFERENCE DISCUSSING UNMET NEEDS IN OPIOID THERAPY

Jan 12, 2006
Elite Pharmaceuticals Enters into an Agreement with Orit Laboratories

Jan 10, 2006
Elite Pharmaceuticals Notified of Continued Listing Noncompliance by Amex

Dec 20, 2005
Elite Announces Amendment to Agreement with IntelliPharmaCeutics

 18   19   20   21   22     23    24   25   26 
 <<   <   >   >> 
  • Site Map   |  Privacy  |  Terms Of Use
Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.
ART™: Abuse-Resistant Technology for a safer healthier you.
Back to top

Privacy
Resize Viewer - Reduce Resize Viewer - Expand Close window